Akkio vs Aidoc
A detailed comparison to help you choose between Akkio and Aidoc.
🏆
Verdict: Aidoc wins
Aidoc scores 4.2/5, edging out Akkio at 3.2/5. Hospital radiology departments and integrated health systems with meaningful acute imaging volumes that want one governed platform for many FDA-cleared triage algorithms instead of a stack of point solutions.
Akkio No-code predictive AI for business teams | Aidoc AI powered radiology image analysis platform | |
|---|---|---|
| Rating | 3.2 (1 review) | 4.2 (1 review) |
| Pricing Model | paid | paid |
| Starting Price | From $49/mo | From $10000/mo |
| Best For | Media and advertising agencies — especially holding-company scale — that want audience building, planning and measurement consolidated with white-label client delivery, and can buy enterprise. | Hospital radiology departments and integrated health systems with meaningful acute imaging volumes that want one governed platform for many FDA-cleared triage algorithms instead of a stack of point solutions. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | no codeteam features | api accessteam featuresgdpr compliant |
| Visit Akkio → | Visit Aidoc → |
Akkio
Pros
- + Agency workflow chain (strategy → audiences → planning → activation → measurement) matches how media teams actually operate
- + White-label Build-On package lets agencies resell analytics under their own brand — the most distinctive capability in the category
- + No-code model building really was accessible: churn-propensity training took about ten minutes in my earlier self-serve testing
- + Serious enterprise validation: Havas holding-company deal across 100+ markets (Jan 2026) plus Horizon Media and LG Ad Solutions
- + Predictive modelling folded into planning and activation rather than sold as an isolated toy
Cons
- - Self-serve pricing is gone — no free tier, no trial, no way to evaluate without a sales process
- - The $49/$99 tiers that still flood review sites are stale and misleading to buyers
- - Small team (~32 people) serving holding-company clients leaves smaller accounts at service risk
- - No-code modelling has a hard ceiling: limited model customization versus a real data science stack
- - The standalone prediction tool that built the reputation is no longer sold on its own
Aidoc
Pros
- + Widest FDA-cleared acute triage portfolio I have reviewed: 31 authorisations on the FDA's December 2025 list, plus the first multi-indication clearance covering 14 abdominal CT findings in one workflow
- + Multi-triage consolidation meaningfully reduces alert noise — one flagged study produces one stacked panel, not one pop-up per algorithm
- + Real-world deployment evidence: Mercy Health documented urgent case turnaround falling from 19.8h to 1.3h across 50+ hospitals, with 5,642 patients expedited from 50,749 flagged findings
- + Vendor-neutral aiOS layer lets a health system run third-party and Aidoc algorithms through one governance and notification stack (17 FDA-cleared algorithms deployed at Hartford HealthCare)
- + Care Coordination and Patient Management close the loop beyond triage: mobile alerts with image context, and report mining that routes incidental findings to facility-defined follow-up protocols
Cons
- - No public pricing, no trial, no free tier — third-party estimates of ~$50k/site/year baseline with $8k-$15k per extra module are unverifiable until you are deep in a sales process
- - Hospital-only: requires PACS/RIS/EHR integration work, so it is irrelevant to individual clinicians, small practices and low-volume facilities
- - 510(k) clearance for most modules does not itself require independent clinical performance data (per JAMA Network Open) — buyers should demand the study set, not just the clearance count
- - No public changelog for algorithm updates, which is a real gap for a system whose output feeds clinical decisions
- - Vendor performance figures (order-of-magnitude false-alert reduction, 1,600+ hospitals) are company claims I could not independently audit
Frequently Asked Questions
Which is better, Akkio or Aidoc?▼
Aidoc scores higher at 4.2/5 vs 3.2/5 for Akkio, making it the better-rated option in our comparison.
What is the difference between Akkio and Aidoc?▼
Akkio: Akkio is an AI analytics platform for media and advertising agencies, used to build audiences, forecast campaign results and automate client reporting. Sold by custom quote. Aidoc: Aidoc analyses medical imaging to flag urgent findings for radiologists and care teams, prioritising the cases that need attention first.
Is Akkio or Aidoc more affordable?▼
Akkio starts at €49/mo, Aidoc starts at €10000/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.